Surgically placed central venous catheters (CVC) are increasingly being replaced by percutaneous CVC (PCVC) for nutritional and fluid support of neonates. (Durand, Pediatrics, 1986) We report successful use of the same small silaatic PCVC in infants and children aged 2 months to 12 9/12 years with weights between 4.4 and 21 Kilograms. Indications for use included post-operative short bowel syndrome, regional ileitis, intractable diarrhea, and meningitis. Although tiny (internal diameter 0.012 inch, outer diameter 0.025 inch) PCVC accommodated flow rates from 2-90 ml/hr and hyperalimentation fluid with concentrations of 25% Dextrose and 20% Intralipids.
more efficient nutrient di~tiori and ebsorptim.Preduodenal lipases have a mpensaton/ function in fat digmiion during physiologic (devalopmental) or pathologic (qstic flbrasls, alchoholism related) pencreetic insufficiency ( JCfjn /rival 67: 838, 1981 ; 73:374, 1984; Psdf; drRaci8:402, 1984 and &t&ev / 1987, in pm) . W e have therefore investipeted whether NNS stimulates the secretion of these lip= in LBW infants. Two separate studies were cwductcdl) 9 infants (gest. ege 30.5i0.8 Surgically placed central venous catheters (CVC) are increasingly being replaced by percutaneous CVC (PCVC) for nutritional and fluid support of neonates. (Durand, Pediatrics, 1986) We report successful use of the same small silaatic PCVC in infants and children aged 2 months to 12 9/12 years with weights between 4.4 and 21 Kilograms. Indications for use included post-operative short bowel syndrome, regional ileitis, intractable diarrhea, and meningitis. Although tiny (internal diameter 0.012 inch, outer diameter 0.025 inch) PCVC accommodated flow rates from 2-90 ml/hr and hyperalimentation fluid with concentrations of 25% Dextrose and 20% Intralipids.
Analgesia was used for the procedure which was performed in the treatment room or the patient's own room. Placement (in the Subclavian vein or Right Atrium) was confirmed by chest x-ray with injection of 0.3cc of Renografin.
PCVC remained in place an average of 29 days (range 5-43 days). Difficulty advancing the catheter from peripheral entry site was noted. Complications included occlusion (treated with Urokinase), dislodgement of the catheter and infection.
Conclusion: PCVC is an alternative to surgically placed CVC and does not require ligation of major veins. They can be placed at the bedside, without general anesthesia, operate at high flow rates, with high viscosity fluids, and remain functional for long periods of time.
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The elevated serum gastrin of the neonate may be the result of maximum stimulation of the G-cell. Epinephrine is a stimulant of gastrin release in adult man.This study evaluated the effects of epinephrine on basal serum gastrin in neonatal pigs. Thirteen Landrace piglets less than fourteen days of age were administered halothane, nitrous oxide, oxygen mixture. After a 15 minute period, IV epinephrine was administered at 25 or 5Onglkglmin for 15 minutes. After a second 30 min stablization, epinephrine was administered at 100 or 200ng/kg/min. Blood samples for gastrin and epinephrine were obtained at 5,10, and 15 minutes of infusion. Samples were assayed for gastrin by radioimmunoassay and epinephrine by high performance liquid chromatography. (Gastrin pg/mltSEM) *p < .05 compared to basal 1) Epinephrine in doses of 25 and 50 ng/kg/min result in a significant decrease in serum gastrin levels. Doses of 100 and 200nglkglmin had no effect on basal gastrin levels. 2) Neonatal gastrin levels appear maximal and the G-cell cannot be stimulated by epinephrine. and vitamin E (MeankSD, E:7+8; L:8k10 pg/ml). Duration of disease (YiSD) was: E 8.0f2.7, L 4.4k3.5 years. RESULTS (51tSD):
MENTAL FUNCTION AND GROWTH IN CHILDREN WITH EARLY (E) VS. LATE (L) ONSET END-STAGE LIVER DISEASE (ESLDI.
.002 .002 .0006 n s .008 ,004 Mental function and growth were significantly delayed in the E group; height deficits suggested stunted growth from severe early malnutrition. We conclude that liver disease during early brain growth has pernicious effects on ultimate intellectual function and linear growth; duration of disease prior to ESLD may also play a role. We speculate that aggressive nutritional support must begin at diagnosis in early onset liver disease to prevent delayed growth and development.
THE KINETICS OF
The earliest known cellular response to transmembrane signalling by ~olypptide growth factors is to stimulate a plasma membrane Na /H exchanger which facilitates mitogenesis through alkalinization of the cytoplasm. W e recently reported (Hepatology 6:1175 (Hepatology 6: , 1986 ) that N~+/H+ exchange activity was markedly enhanced in basolateral plasma membrane vesicles (BLMV) isolated from neonatal (7 days) rat liver. The purpose of this study was to define the mechanism for this increase by determining the kinetics of Naf/HC exchange in B L M V prepared from neonata) and adult liver by a Percoll gradient method. The initial rate of 2~a + uptake (7 sec) was assayed in the presence of an outwardly directed transmembrane proton gradient (pH 5.5 inside, pH 7.5 outside) using a rapid-quench Millipore filtration technique. Total ~a + uptake measured as a function of extravesicular [ N a ' l (0.5 to 30 m M ) was curvilinear and significantly higher in neonatal compared with adult BLMV. The passive component of uptake, estimated in the presence of the inhibitor amiloride, increased linearly with the [ N~+ I concentration and was similar at each age. Computer analysis of the amiloride-sensitive portion of Na+ uptake (via N~+/H+ exchange) revealed saturable kinetics with a similar K m (8.6 2 1.6 vs. 8.1 + 1.5 mM) but a 2.5-fold higher Vmax (8.06 + 0.67 vs, 3.20 + 0.40 nmollmg -proteinlmin, p 2 0.01) in neonatal vs. adufi vesicles. Weconclude from these studies that enhanced N~+/H+ exchange activity in neonatal liver, which may he essential for regulation of cell proliferation and growth, results from an increased incorporation of functional carriers into the plasma membrane or an increased translocation rate of existing carriers.
